Skip to Main Content

Paper Details

An intranasal recombinant NDV-BRSV F<sub>opt</sub> vaccine is safe and reduces lesion severity in a colostrum-deprived calf model of RSV infection.
Sci Rep
0
2022
Author NameAffiliation
Ignacio MenaIcahn School of Medicine at Mount Sinai
Ignacio MenaIcahn School of Medicine at Mount Sinai, Global Health and Emergent Pathogens Institute
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai, Global Health and Emergent Pathogens Institute
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai, The Tisch Cancer Institute
Adolfo Garc??a-SastreIcahn School of Medicine at Mount Sinai
  • 1 - 7

Datasets

Release 1.2